Atlas Trials

Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

Clinical trial NCT01588431 · COMPLETED

Trial details

NCT number
NCT01588431
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Squamous Cell of Head and Neck
Start date
2011-12-01
Primary completion
2022-10-04
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.